Xcout Intel
Zoetis
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Subscribe to see Zoetis’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Zoetis at a glance
Zoetis is a pharmaceuticals company headquartered in Parsippany, United States. It is publicly listed (ZTS) with a market capitalisation of $30.6B. Xcout tracks 29 named people at Zoetis, including Kristin C Peck (Chief Executive Officer & Director). Xcout recorded 218 job postings from Zoetis in the last 90 days, naming tools such as SAP, Power BI, Salesforce.
Zoetis leadership
- Kristin C PeckChief Executive Officer & Director
- Wetteny N. JosephSpecial Advisor to the CEO
- James K. SaccaroExecutive VP, CFO & COO
- Jamie BrannanExecutive Vice President & Chief Commercial Officer
- Jeannette Ferran AstorgaExecutive Vice President of Corporate Affairs & Chief Sustainability Officer
- Julie A. FullerExecutive Vice President, Chief Human Resources Officer & Global Operations
23 more named people on record for Zoetis, with roles, board committees and tenure — see the full roster →
Hiring at Zoetis
Xcout recorded 218 job postings from Zoetis in the last 90 days, from a hiring record Xcout has kept since May 2026.
Tools named in Zoetis's job postings
The weekly hiring trend, the roles and locations behind it — see Zoetis's hiring signals →
Tech stack
Zoetis competitors
A few of Zoetis's closest competitors — see the full list of competitors and alternatives →
Merck Animal Health is a research-driven company headquartered in Rahway, New Jersey, USA. It develops, manufactures, and markets a broad range of veterinary medicines, products, technologies, and services to advance animal healthcare.
Virbac provides a comprehensive range of products, vaccines, parasiticides, diagnostics, and services for veterinarians, farmers, and pet owners globally. The company focuses on animal health and care for both companion animals and farm species such as cattle, aquaculture, and swine.
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Aurora Pharmaceutical, LLC develops, manufactures, and distributes veterinary pharmaceutical products and animal health solutions. The company serves livestock producers, veterinarians, and companion animal owners with a portfolio focused on parasite management, reproduction, wound care, and general health for cattle, swine, poultry, equine, and small animals.
Vetoquinol S.A. is a pharmaceutical company dedicated to animal health, responsible for researching, formulating, and distributing veterinary medicines and other health-related products throughout Europe, the Americas, and the Asia Pacific. The firm offers a comprehensive range of solutions for various therapeutic areas, including pain and mobility management, inflammatory conditions, dermatology, hygiene, parasite control, udder health, infectious diseases, reproductive care, behavioral issues, internal medicine, and cardiovascular-renal disorders. These products are developed for a diverse clientele of animals, encompassing livestock such as cattle, sheep, pigs, and poultry, alongside domestic dogs. Founded in 1933, Vetoquinol S.A. maintains its headquarters in Lure, France, and operates as a subsidiary of Soparfin SCA.
Elanco Products Company is an Elanco Animal Health subsidiary involved in the development, manufacture, and/or sale of animal-health products. Its products serve companion-animal owners and veterinarians as well as livestock producers and animal-health professionals.
Get Zoetis's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Zoetis in Xcout Intel
- 29 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access